Immunotherapy for Head and Neck Cancer
Speaker
.jpg)
Presented in HYBRID format. Attend in-person in Arthur E. Corby Auditorium (B-13) or Online.
Marcus A. Couey is Assistant Professor in the Department of Oral and Maxillofacial Surgery at Boston University. He earned his DDS from Columbia University and his MD from the University of Texas, Houston. Following surgical residency training at UT Houston, he completed a research fellowship in Immuno-Oncology at the Earle A. Chiles Research Institute in Portland, OR, where he focused on the development of immuno-oncology clinical trials, immunotherapy toxicity and biomarkers for response to immunotherapy. He went on to complete fellowship training in Head and Neck Oncologic Surgery and Microvascular Reconstructive Surgery at Providence Cancer Institute in Portland, OR.
Dr. Couey specializes in the management of cancers involving the mouth, throat, and salivary glands, benign jaw tumors, facial trauma, and microvascular reconstructive surgery. He is active in oncology research, and has published numerous peer-reviewed articles, textbook chapters and abstracts. In addition to providing high-level care for complex maxillofacial pathologies, he aims to develop new treatment strategies that incorporate immunotherapy to improve outcomes for patients with head and neck cancer.
Disclosure: Dr. Couey has no relevant financial relationships to disclose.
Course Description
The development of immunotherapies such as checkpoint inhibitors has transformed the practice of oncology. This lecture will cover the principles of cancer immunotherapy, its current applications in head and neck cancer, combinations of immunotherapy with standard therapies, and future directions of research within the field.
Educational Objectives
- Principles of cancer immunotherapy
- Current FDA approved indications for immunotherapy for head and neck cancer
- Emerging role of immunotherapy in the neoadjuvant setting
- Future directions
Contact
PDMContinuingEd@dental.upenn.edu